<DOC>
	<DOCNO>NCT00901030</DOCNO>
	<brief_summary>This study examine degree blood thinning ( platelet function ) patient come non-cardiac surgery antiplatelet agent use platelet function test call thromboelastography ( TEG ) platelet map assay ( PMA ) major cardiac complication occur time surgery ( perioperative ) .</brief_summary>
	<brief_title>Association Between Perioperative Platelet Function Major Adverse Perioperative Events</brief_title>
	<detailed_description>Patients stent coronary artery ( PCI ) stay antiplatelet agent prevent clot stent . These patient often require non-cardiac surgery ( NCS ) stage PCI . The rate major cardiac complication ( MACE ) population high unclear high risk general population . It possible antiplatelet adequate , surgery cause clot prone . This prospective , multicentre observational study .</detailed_description>
	<criteria>patient age 3085 year old , receive postPCI aspirin and/or clopidogrel therapy patient undergoing nonambulatory , NCS patient receive bare metal coronary stent within last 12 month drug elute stent time prior NCS type surgery contraindictions remain antiplatelet agent surgeon must agree keep patient least one antiplatelet agent perioperative period clot abnormality drug affect platelet function aspirin clopidogrel moderate renal impairment liver dysfunction coexist thrombocytopenia</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>platelet function</keyword>
	<keyword>perioperative complication</keyword>
	<keyword>thromboelastography</keyword>
	<keyword>coronary stent</keyword>
	<keyword>non-cardiac surgery</keyword>
</DOC>